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To elucidate the local epidemiology of Staphylococcus aureus bacteraemia, we characterised blood culture isolates using 
molecular methods and prospectively collected clinical data to determine the occurrence of community-acquired, methicillin-
resistant S. aureus (MRSA). Consecutive S. aureus blood culture isolates were collected over a one-year period from patients who 
were admitted to Tygerberg Academic Hospital in the Western Cape. A multiplex polymerase chain reaction (PCR) was used for 
the detection of spa, mecA and lukS/F-PV genes. Strain typing was performed using spa typing. Multiplex PCR for staphylococcal 
cassette chromosome mec (SCCmec) typing was also performed, as well as multilocus sequence typing (MLST) on selected 
isolates. Cases were categorised by clinical data as either hospital-acquired, healthcare-associated or community-acquired. 
One hundred and thirteen S. aureus isolates (30% MRSA) were collected from 104 cases of bacteraemia. According to clinical 
data, all community-acquired infections, 54% of hospital-acquired cases and the majority of healthcare-associated cases were 
due to methicillin-sensitive S. aureus (MSSA). Furthermore, all Panton-Valentine leukocidin (PVL)-positive isolates (15.9% of all 
S. aureus) were MSSA. MRSA strains were isolated from hospital-acquired cases (with a minority of healthcare-associated 
cases) and clustered mainly in spa-CC701 and CC012. SCCmec type IV was predominant. MLST clones included ST239-MRSA-
III, ST36-MRSA-II and ST612-MRSA-IV. The predominant source for S. aureus bacteraemia was catheter-related infection (39%). 
Community-acquired S. aureus infections in our setting remain sensitive to methicillin and current treatment guidelines suffice. 
The majority of hospital-acquired and healthcare-associated infections were catheter-related. Prevention and treatment should 
be targeted accordingly.
 Peer reviewed. (Submitted: 2012-03-23. Accepted: 2012-05-31.) © SAJEI South Afr J Epidemiol Infect 2013;28(1):22-27
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Introduction
The prevalence of community-acquired, methicillin-resistant 
Staphylococcus aureus (MRSA) infection in South Africa 
is unknown. Two recent studies described the molecular 
characterisation of MRSA in South Africa and  identified MRSA 
clones such as ST5-MRSA-I, ST239-MRSA-III and ST36-
MRSA-II, which are found worldwide, and ST612-MRSA-IV, 
which to date has only been described in South Africa and 
Australia.1,2. In this study, we characterised MRSA and MSSA 
isolates from bacteraemia episodes using molecular methods 
and prospectively collected demographic and clinical data on 
these patients to determine the prevalence of community-
acquired MRSA according to the clinical definition. 
Materials and method
Collection of isolates
Consecutive nonduplicate S. aureus blood culture isolates 
were prospectively collected from April 2008 to May 2009 from 
patients who were admitted to Tygerberg Academic Hospital in 
the Western Cape. Polymicrobial blood cultures were excluded 
from the study. Isolates were identified by conventional 
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laboratory methods and stored at -800C for further molecular 
typing. Antibiotic susceptibility testing was performed using 
the disc diffusion method and interpreted according to the 
Clinical and Laboratory Institute criteria.3 Antibiotics that are 
routinely tested against S. aureus in our laboratory include 
penicillin, cefoxitin, gentamicin, erythromycin, clindamycin, 
rifampicin, fusidic acid, cotrimoxazole and vancomycin. 
Vancomycin minimum inhibitory concentrations were 
determined by Etest® (Biomérieux, France). 
Definition of cases
A case was defined as an episode of S. aureus bacteraemia. 
An isolate for each episode (case) was included in the study 
when > 1 episode of S. aureus bacteraemia occurred (positive 
blood culture > 7 days after appropriate antimicrobial therapy 
was initiated and source control established). 
Demographic and clinical data
Demographic and clinical data were prospectively obtained. 
Clinical information was attained at the time of telephonic 
reporting of the positive blood culture result. Further 
information was gathered through formatted interviews 
with the patient using a questionnaire that included specific 
questions, from the laboratory information system and from 
medical records. 
Collected data included age, gender, ward, human immuno-
deficiency virus (HIV) status, other underlying medical conditions, 
previous hospitalisation and antimicrobial therapy. A record was 
also kept of dates of admission and blood culture collection, 
data on infective parameters, culture of S. aureus from other 
specimens, antimicrobial therapy and response to treatment. 
The source of infection was determined according to the 
presence of clinical signs or other radiological investigations 
that indicated the primary site of infection with or without the 
culture of S. aureus from specimens that were collected from 
the primary site of infection, and without any other obvious 
source of infection.
The clinical outcome of each case was recorded as either 
discharged from hospital, transferred to another hospital or 
demised.
Definitions of clinical categories4,5
•	 Hospital-acquired bacteraemia: This was defined as a 
positive blood culture collected more than 48 hours after 
admission without evidence of a S. aureus infection at 
the time of admission. If the patient was transferred from 
another hospital, the duration was considered to begin 
from the date of the first hospital admission.
•	 Healthcare-associated bacteraemia: This was defined as 
a positive blood culture collected at the time or within 48 
hours of hospital admission from patients who had been 
hospitalised or dialysed within the previous year or who 
were resident in a nursing home or long-term care facility.
•	 Community-acquired bacteraemia: This was defined as a 
positive blood culture collected within 48 hours of hospital 
admission from patients without a history of healthcare 
exposure.
Cases in which clinical information was lacking were not 
categorised according to the above criteria as the exact time of 
the onset of the infection could not be established. These cases 
were categorised as either “primary bacteraemia”, where the 
source of infection was unknown, but infective parameters 
indicated infection, or “unknown” where clinical data were 
limited and clinical significance could not be established.
Strain typing and molecular characterisation
A multiplex polymerase chain reaction (PCR) was used for the 
simultaneous detection of the spa, mecA and Panton-Valentine 
leucocidin lukF/S-PV (PVL) genes according to a previously 
described protocol.6 Strain typing was performed after 
sequencing of all isolates with positive spa PCR amplicons 
as previously published. Spa types were assigned using the 
Ridom StaphType® software package version 1.4 (Ridom 
Gmb, Würzburg, Germany) and spa clonal complexes (spa-
CC) assigned using the BURP (Based Upon Repeat Pattern) 
algorithm of the software. 
A multiplex PCR strategy was employed that allowed for the 
discrimination of staphylococcal cassette chromosome mec 
(SCCmec) types (I-V).7 Multilocus sequence typing (MLST) was 
performed on selected isolates only as previously published.8 
MLST sequence types were assigned using the S. aureus 
database on the www.mlst.net website, and clonal complexes 
(CC) assigned using the based-upon-related-sequence-
types (eBURST) algorithm that is available on the website. 
A representative isolate was randomly selected from each 
major spa-CC (≥ 4 spa types) as well as the most frequent spa 
types in the study. Where > 1 SCCmec type was found within 
a spa-CC, a representative isolate was randomly selected for 
each SCCmec type. Where only one isolate was available for a 
specific SCCmec type in the spa-CC, that isolate was selected. 
Statistical analyses
Data were analysed using the Statistica® chi-square test. A 
p-value ≤ 0.05 was considered to be statistically significant.
Ethical approval
Ethical approval was obtained from the Health Research Ethics 
Committee of the Faculty of Health Sciences, Stellenbosch 
University on 8 October 2008 (Project number: N08/09/252). 
Results
Description of cases and demographic data
One hundred and thirteen S. aureus isolates (34, 30% MRSA) 
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from 104 patients were included in the study. In five patients, 
more than one episodes of bacteraemia were clinically 
identified, therefore an isolate from each episode was included 
in the study. 
Table I lists the patients’ demographic and clinical data.
Site of primary infection and categorisation according 
to clinical onset
Catheter and prosthetic device-related bacteraemia was the 
most common primary site of infection that was identified. Most 
of these cases resulted from intravascular catheter infections. 
Furthermore, 86 of the 113 bacteraemia episodes could 
be clinically categorised as hospital-acquired, healthcare-
associated or community-acquired, as shown in Figure 1. 
A significant finding was that all 13 community-acquired 
infections were due to MSSA and that no community-acquired 
MRSA was detected in our study. Community acquired-
infections included pneumonia, skin and soft tissue infections, 
septic arthritis or osteomyelitis and infective endocarditis. 
Of the MRSA infections, 23 (88%) were hospital-acquired. 
A minority of MRSA infections were healthcare-associated 
(3, 11.5%). Healthcare-associated bacteraemia occurred 
in patients with chronic renal failure on haemodialysis or 
peritoneal dialysis and who developed catheter-related 
infection. The majority of healthcare-associated infections 
were due to MSSA (20, 87%).
CA: community-acquired, HA: hospital-acquired, HCA: healthcare-associated, MRSA: 
methicillin-resistant Staphylococcus aureus, MSSA: methicillin-sensitive Staphylococcus 
aureus
Figure 1: Comparison of methicillin resistant Staphylococcus aureus and 
methicillin-sensitive Staphylococcus aureus hospital-acquired, healthcare-
associated and community-acquired infections (chi-square (df = 2) = 18.6, 
p-value = 0.00009)
Strain characteristics
mecA was detected in 33 of 34 MRSA isolates, PVL genes 
in 18 of the 113 S. aureus isolates (15.9%) and spa in 101 
isolates (89%). PVL was detected in 18 of the 79 MSSA strains 
(22.7%), whereas none of the MRSA strains tested positive 
for PVL. Forty-nine spa types were identified, including five 
novel types. Table II shows the most frequent spa types, 
each representing  ≥ 5 isolates in this study. Apart from the 
singleton, t891, these common spa types represent the major 
spa-CC in this study. These strains were isolated from patients 
from a variety of wards, but the numbers of isolates per ward 
were too low to determine if there was any association with 
specific wards.
Table II: Most frequent spa types detected in the study (n = 101)







An unweighted pair group method using average linkages 
dendogram shows the clustering of spa types into spa-
CC (Figure 2). Two spa types were excluded from cluster 
analyses as they contained < 5 repeats, which is insufficient 
to deduct evolutionary history. Assessment of the four major 
spa-CC, representing 70 (62%) of all isolates, displayed that 
MRSA strains (n = 30) clustered predominantly in spa-CC701 
 Table I: Demographic and clinical data
Patient information Number (%)
Demographics (n = 104 patients)








Clinical outcome (n = 102 patients)
Discharged 63 (62%)
Transferred to another hospital 12 (12%)
Demised 27 (26%)
Source of infection (n = 113 cases) 
Catheter and prosthetic device-related infection 44 (39%)
Skin and soft tissue infection 20 (18%)
Primary bacteraemia 15 (13%)
Pneumonia 13 (11%)
Unknown 11 (10%)
Septic arthritis and osteomyelitis 5 (4%)
Infective endocarditis 3 (3%)
Other (pericarditis and urinary tract infection) 2 (2%)
Onset of infection (n = 86 cases) 
Hospital-acquired bacteraemia 50 (58%)
Healthcare-associated bacteraemia 23 (27%)
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TBH 30.e  t012
TBH 38  t275
TBH 26.b  t253
TBH 9  t018
TBH 7.b  t037
TBH 40.a  t021
TBH 58  t318 
TBH 2  t030
TBH 15  t433
TBH 37  t1848




































TBH 11 t891 


















Figure 2: An unweighted pair group method using average linkages dendogram of spa types clustering into spa-CC
(Only one representative strain per spa type is shown)
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(13, 43%) and spa-CC012 (16, 53%), compared to spa-CC015 
(1, 3%) and spa-CC002 (0, 0%). MSSA showed a diverse 
genetic background and was identified in all spa-CC, as well 
as numerous singletons (p-value = 0.0016 for the association 
between major spa-CC and MRSA/MSSA).
SCCmec typing of MRSA isolates showed type IV to be the 
dominant type (16, 47%) followed by SCCmec III, II and V, 
with 8 (23%), 6 (18%) and 2 (6%), respectively. Type IV MRSA 
constituted multi-resistant phenotypes, with resistance to ≥ 3 
non-beta-lactam antibiotics for 15 isolates and resistance to 
two non-beta-lactam antibiotics in one isolate.
The MLST clonal lineages and antimicrobial resistance profiles 
of selected strains are shown in Table III. The singleton, t891, 
was also selected for MLST because it was the second 
most frequent spa type in the study, following t037 which 
represented the major spa-CC012.
Clinical outcome of cases
Clinical outcome was obtained for 102 of the 104 patients 
(Table I) of which 27 patients (26%) demised. Of the patients 
that survived, two patients presented with both a MSSA and 
a MRSA episode. Therefore, both episodes for each patient 
were included in the MSSA and MRSA groups respectively to 
compare the fatality ratios of the patients with MRSA vs. those 
with MSSA. Ten (31%) of the 32 MRSA patients demised, 
compared to 17 (24%) of the 72 MSSA patients. These 
numbers did not achieve statistical significance (p-value = 
0.412). None of the MRSA case fatalities were due to PVL-
positive strains. In the MSSA group, 17 patients demised 
(3 PVL-positive, 17.6%) and 55 patients survived (15 PVL-
positive, 27%). The number of PVL-positive cases was too 
low to determine statistical significance between the cases of 
survival and fatality.
Discussion
This study provides data on the molecular characterisation of 
S. aureus bloodstream isolates that are linked to prospective 
clinical data at Tygerberg Academic Hospital. 
In our setting, 30% of S. aureus bloodstream isolates 
were identified as MRSA. Of note is that none of the MRSA 
cases were community-acquired. This is in contrast to the 
emergence of community-acquired MRSA that has been 
reported from other countries.4 Therefore, in our setting, 
cloxacillin or other beta-lactam agents are still suitable to treat 
patients with suspected community-acquired staphylococcal 
infections. Furthermore, the virulence factor, PVL, has been 
associated with community acquired-MRSA, but in this 
study, PVL was only detected in MSSA isolates. Only three 
of the PVL-positive cases demised. Similar findings have 
been reported by Nickerson et al from Thailand.9 That study 
included a larger proportion of MSSA isolates, predominantly 
community-acquired skin and soft tissue infections, but all 
PVL-positive isolates were MSSA and constituted 49% of all 
isolates. In addition, in that study, PVL-positive isolates were 
strongly associated with survival compared to PVL-negative 
isolates. In our study, overall mortality was 26%. Mortality 
that was associated with MRSA bacteraemia was higher than 
that linked to MSSA bacteraemia, but this finding was not 
found to be statistically significant. In the study by Nickerson 
et al,9 overall bacteraemia-associated patient mortality was 
53% and was linked to MRSA. No community-acquired MRSA 
infections were detected in that setting as well.
The spectrum of primary sites of infection that are associated 
with bacteraemia reflects the local epidemiology of S. aureus 
at our institution. The majority of infections were hospital-
acquired and related to intravascular catheters, particularly in 
renal patients receiving haemodialysis and in patients in the 
intensive care units. A wide range of spa types were identified 
in these cases and no specific strain was associated with 
intravascular catheter infections. A high number of hospital-
acquired and healthcare-associated infections were due to 
MSSA. This may reflect the endogenous route of infection in 
carriers. Exogenous acquisition may also occur because of 
lack of adherence by staff to infection prevention measures, 
such as hand hygiene. Overcrowded units and staff shortages 
are common problems in our resource-constrained setting.
 
Hospital-acquired strains were mainly found to cluster in 
spa-CC 701 and spa-CC-012. MLST typing of selected strains 





SCCmec Spa typing PVL Antimicrobial resistance profile
ST CC spa Spa-CC
TBH107 239 8 MRSA III t037 012 Neg PEN, FOX, GEN, ERY, CLI, COTR
TBH69 239 8 MRSA V t037 012 Neg PEN, FOX, GEN, ERY, CLI, COTR
TBH9 612 8 MRSA IV t018 012 Neg PEN, FOX, ERY, CLI
TBH13 612 8 MRSA IV t1443 701 Neg PEN, FOX, GEN, RIF, COTR
TBH86 36 30 MRSA II t021 012 Neg PEN, FOX, GEN, ERY, CLI
TBH17 2090 45 MRSA IV t015 015 Neg PEN, FOX, GEN, ERY, CLI, RIF, COTR
TBH57 650 5 MSSA N/A t306 002 Neg PEN
TBH11 217 22 MSSA N/A t891 Singleton Pos PEN, GEN
CC: clonal complex, CLI: clindamycin, COTR: co-trimoxazole, ERY: erythromycin, FOX: cefoxitin, GEN: gentamicin, MLST: multilocus sequence typing, MRSA: methicillin resistant Staphylococcus 
aureus, N/A: not applicable, Neg: negative, PEN: penicillin, Pos: positive, PVL: Panton-Valentine leucocidin, RIF: rifampicin, SCCmec: staphylococcal cassette chromosome mec, ST: sequence type
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identified clones that are found globally, such as ST239-
MRSA-III and ST36-MRSA-II. In accordance with another 
recent study from Cape Town that focused on MRSA only, the 
ST612-MRSA-IV clone was identified as a dominant MRSA 
clone.2 This clone has only been described in South Africa 
and Australia.2 Interestingly, t037, t021 and t018 clustered 
together in spa-CC012, although from different MLST clones, 
CC8 and CC30, and SCCmec types. Robinson and Enright 
reported that chromosomal replacement in the MRSA isolates 
of CC8 with a large genetic element containing the spa gene 
from ST30 (CC30) resulted in ST239 (CC8).10 Furthermore, a 
novel MLST sequence type, ST2090-MRSA-IV, was identified 
from a strain  characterised as t015 (spa-CC015) and was 
the only MRSA isolate among six that were characterised as 
t015. This may reflect the local emergence of a new MRSA 
sequence type. This strain was isolated from a one-year-old 
HIV-negative infant after > 1 month of hospitalisation. 
A possible limitation of the study was the limited clinical data, 
particularly pertaining to the group of cases classified as 
“unknown”, as we were unable to rule out isolates that may 
have been contaminants in this group.
In conclusion, we identified no community-acquired MRSA in 
our setting. Cloxacillin is still the agent of choice for treating 
community-acquired S. aureus infection. The majority of 
isolates were derived from cases defined as hospital-acquired 
and the major source was intravascular catheter-related 
infection. This information will be useful when targeting 
infection control and prevention practices to reduce S. aureus 
bacteraemia in our setting.
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